MAVALON THERAPEUTICS
Mavalon Therapeutics is a company focused on stopping the progression of Parkinson’s disease. The biotechnology company is developing mGluR3 allosteric modulators for the treatment of Parkinson's disease.
MAVALON THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2016-01-01
Address:
Hatfield, Hertford, United Kingdom
Country:
United Kingdom
Total Employee:
1+
Status:
Active
Total Funding:
9 M EUR
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Vincere Biosciences
Vincere Biosciences is a JLABS incubator company whose mission is to develop drugs to halt the progression of Parkinson's disease (PD).
Investors List
Domain Therapeutics
Domain Therapeutics investment in Seed Round - Mavalon Therapeutics
Medicxi
Medicxi investment in Seed Round - Mavalon Therapeutics